| 000 | 01796 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515212113.0 | ||
| 264 | 0 | _c20100602 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1557-8577 | ||
| 024 | 7 |
_a10.1089/rej.2009.0908 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYu, Song | |
| 245 | 0 | 0 |
_aCurcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway. _h[electronic resource] |
| 260 |
_bRejuvenation research _cFeb 2010 |
||
| 300 |
_a55-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAstrocytes _xdrug effects |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCurcumin _xpharmacology |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aNerve Degeneration _xchemically induced |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-jun _xmetabolism |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 700 | 1 | _aZheng, Wei | |
| 700 | 1 | _aXin, Na | |
| 700 | 1 | _aChi, Zhi-Hong | |
| 700 | 1 | _aWang, Nai-Qian | |
| 700 | 1 | _aNie, Ying-Xue | |
| 700 | 1 | _aFeng, Wan-Yu | |
| 700 | 1 | _aWang, Zhan-You | |
| 773 | 0 |
_tRejuvenation research _gvol. 13 _gno. 1 _gp. 55-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/rej.2009.0908 _zAvailable from publisher's website |
| 999 |
_c19596329 _d19596329 |
||